Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
NewGenIvf Group Ltd
NewGenIvf Group will implement a 1-for-8 reverse stock split effective October 23, 2026. This action is expected to reduce the total number of outstanding shares from approximately 9,821,197 to approximately 1,227,650, while the shares will continue to trade under the ticker symbol 'NIVF'.…more
NewGenIvf Group Ltd
NewGenIvf Group reported its financial results for the first half of 2026, posting revenue of $1.92 million and a net loss of $8.03 million. The company executed four reverse stock splits between January and September 2026, and held $1.02 million in cash and cash equivalents as of June 30, 2026.…more
NewGenIvf Group Ltd
NewGenIvf Group will implement a 1-for-4 reverse stock split effective October 12, 2026. This action will reduce the total outstanding Class A ordinary shares from approximately 35.69 million to 8.92 million, with trading continuing on Nasdaq under the ticker 'NIVF'.…more
37 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
NewGenIvf Shares Surge Following $1.25M Public Offering
NewGenIvf shares jumped in after-hours trading after the company announced the closing of a $1.25 million public offering. The offering includes significant share issuance and warrants, which raises concerns regarding potential shareholder dilution.…more
●●●●●●●● ●●●●● ●●●●●●
NewGenIVF announced the closing of a public offering raising approximately $1.25 million in gross proceeds. The company plans to use the funds for debt restructuring and general working capital purposes.…more
●●●●●●●● ●●●●● ●●●●●●
NewGen has priced a public offering of approximately 17.86 million ordinary shares or pre-funded warrants at $0.07 per share. This capital raise is expected to result in shareholder dilution, which is typically viewed negatively by investors.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.